Background: Familial aggregation of congenital heart disease (CHD) has been well described in different populations, in particular those with a high consanguinity rate. Extensive genetic study of affected families has improved the understanding of basic genetics of different cardiac lesions. Objective: To identify the role of consanguinity as a risk factor among familial cases of CHD in a stable outpatient population of a tertiary care center in the Eastern Province of Saudi Arabia. Methods: All familial cases of CHD seen over 5 years (1996–2000) in the Division of Pediatric Cardiology were identified. The presence or absence of parental consanguinity (first cousin marriage) was defined in each of these families. Results: Ninety-three cases were identified in 37 families. Twenty-three (62%) families resulted from consanguineous marriages. In 4 families where there were 2 marriages, the affected children came from the consanguineous marriage in 3 of these families. Discordant lesions occur only among non-consanguineous cases, while all consanguineous cases were concordant. Five sets of twins of the same sex (one set are monozygotic by DNA analysis) occurred among consanguineous marriages, in 3 of these both twins were affected with the same disease. Affected parents were seen in 2 families with consanguineous marriage and none in the non-consanguineous marriages. The prevalence of dilated cardiomyopathy was much higher among consanguineous cases (26 vs. 2). Conclusions: Familial aggregation of congenital heart disease is common in our population. Consanguinity is common in these families, and the distribution of congenital heart disease differs in this subgroup compared to the rest of the familial cases. Further genetic studies of these families may help to shed more light on basic genetics and the specific pathogenetic mechanisms involved.

Keywords:
Consanguinity, Congenital heart disease
1.
Farag TI, Teebi AS: Genetic disorders among the Bedouins; in Teebi AS Farag TI (eds): Genetic Disorders among Arab Populations. New York, Oxford University Press, 1997, pp 375–410.
2.
Becker S, Al Halees Z: First-cousin mating and congenital heart disease in Saudi Arabia. Community Genet 1999;2:69–73.
3.
Hoess K, Goldmuntz E, Pyeritz RE: Genetic counseling for congenital heart disease. New approaches for a new decade. Curr Cardiol Rep 2002;4:68–75.
4.
Digilio MC, Casey B, Toscano A, Calabro R, Pacileo G, Marasini M, Banaudi E, Giannotti A, Dallapicola B, Marino B: Complete transposition of the great arteries: patterns of congenital heart disease in familial precurrence. Circulation 2001;104:2809–2814.
5.
Huntington K, Hunter AG, Chan KL: A perspective study to assess the frequency of familial clustering of congenital bicuspid aortic valve. J Am Coll Cardiol 1997;30:1809–1812.
6.
Corone P, Bonaiti C, Feingold J, Fromont S, Berthet-Bondet D: Familial congenital heart disease. How are the various types related? Am J Cardiol 1983;51:942–945.
7.
Goldmuntz E: Recent advances in understanding the genetic etiology of congenital heart disease. Curr Opin Pediatr 1999;11:437–443.
8.
Seliem MA, Manasra KB, Pablea M, Ye X, Zhang Z, Benson DW: Evidence for autosomal recessive inheritance of infantile dilated cardiomyopathy: studies from the eastern province of Saudi Arabia. Pediatric Res 2000;48:770–775.
9.
Becker S, Al-Halees Z, Molina C, Paterson RM: Consanguinity and congenital heart disease in Saudi Arabia. Am J Med Genet 2001;9:8–13.
10.
Bassili A, Mokhtar SA, Dabous NI, Zaher SR, Mokhtar MM, Zaki A: Risk factors for congenial heart diseases in Alexandria, Egypt. Eur J Epidemiol 2000;16:805–814.
11.
Roodpeyma S, Kamali Z, Afshar F, Naraghi S: Risk factors in congenital heart disease. Clin Pediatr (Phila) 2002;41:653–658.
12.
Venugopalan P, Agarwal AK: Spectrum of congenital heart defects associated with Down syndrome in high consanguineous Omani population. Indian Pediatr 2003;40:398–404.
13.
Henwood J, Pickard C, Leek JP, Bennett CP, Crow YJ, Thompson JD, Ahmed M, Watterson KG, Parsons JM, Roberts E, Lench NJ: A region of homozygosity within 22q11.2 associated with congenital heart disease: recessive DiGeorge/velocariofacial syndrome? J Med Genet 2001;38:533–536.
14.
Mani A, Meraji SM, Houshyar R, Radhakrishnan J, Mani A, Ahangar M, Rezaie T, Taghavinejad MA, Broumand B, Zhao H, Williams CN, Lifton RP: Finding genetic contribution to sporadic disease: a recessive locus at 12q24 commonly contributes to patent ductus arteriosus. Proc Natl Acad Sci USA 2002;99:15054–15059.
15.
Maestri NE, Beaty TH, Liang KY, Boughman JA, Ferencz C: Assessing familial aggregation of congenital cardiovascular malformations in case-control studies. Genet Epidemiol 1988;5:343–354.
16.
Boughman JA, Berg KA, Astemborski JA, Clark EB, McCarter RJ, Rubin JD, Ferencz C: Familial risks of congenital heart defect assessed in population-based epidemiologic study. Am J Med Genet 1987;26:839–849.
17.
Digilio MC, Marino B, Canepa SA, Borzaga U, Giannotti A, Dallapiccola B: Congenital heart defect in sibs with discordant karyotypes. Am J Med Genet 1998;80:169–172.
18.
Maestri NE, Bealy TH, Boughman JA: Etiologic heterogeneity in the familial aggregation of congenital cardiovascular malformations. Am J Hum Genet 1989;45:556–564.
19.
Ferencz C, Boughman JA, Neil CA, Brenner JI, Perry LW: Congenital cardiovascular malformations: questions on inheritance. Baltimore-Washington infant study group. J Am Coll Cardiol 1989;14:756–763.
20.
Nora JJ, Nora AH: Maternal transmission of congenital heart diseases: new recurrence risk figures and the question of cytoplasmic inheritance and vulnerability to teratogens. Am J Cardiol 1987;59:459–463.
21.
Burn J, Brennan P, Little J, Holloway S, Coffey R, Somerville J, et al: Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet 1998;351:311–316.
© 2007 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.